Phenoxymethylpenicillin-AFT (Penicillin V) now in Australia

In addition to the four products on the Pharmaceutical Schedule, Budenocort Powder for Inhalation, Aramed, Acetadote IV and Provive MCT-LCT. Australia, AFT Pharmaceuticals is delighted to achieve further PBS listings to the four listed, Phenoxymethylpenicillin-AFT (Penicillin V) Oral Liquid 125mg/5ml & 250mg/5ml strengths on the PBS from 01 June 2011.

This restores the original penicillin oral liquid strengths to the PBS adding to choice available to Australian doctors and patients.

“These new listings will add to AFT’s extensive list of products on the Pharmaceutical Schedule”, said CEO and founder Dr Hartley Atkinson.

July 23, 2026

Pitt St Research initiates coverage on AFT Pharmaceuticals

AFT Pharmaceuticals (NZX: AFT; ASX: AFP), today announces that Pitt St Research has initiated coverage on AFT Pharmaceuticals Ltd….

Read More

May 21, 2026

AFT delivers double digit revenue growth and record earnings

Operating profit or $24.4 million ahead of the guidance range….

Read More

May 18, 2026

AFT Pharmaceuticals names Stuart Houliston CFO

AFT Pharmaceuticals (NZX: AFT; ASX: AFP), New Zealand’s largest domestic pharmaceuticals company, today advises that Stuart Houliston will commence …

Read More